Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / NBRV - Nabriva Therapeutics GAAP EPS of -$0.24 revenue of $9.26M


NBRV - Nabriva Therapeutics GAAP EPS of -$0.24 revenue of $9.26M

Nabriva Therapeutics press release (NASDAQ:NBRV): Q4 GAAP EPS of -$0.24. Revenue of $9.26M (+276.4% Y/Y). Shares -4%. "We remain focused on driving growth of SIVEXTRO, educating the medical community on the benefits of XENLETA, and expanding XENLETA geographically as we continue to assess partnership opportunities," said CEO Ted Schroeder.

For further details see:

Nabriva Therapeutics GAAP EPS of -$0.24, revenue of $9.26M
Stock Information

Company Name: Nabriva Therapeutics plc
Stock Symbol: NBRV
Market: NASDAQ

Menu

NBRV NBRV Quote NBRV Short NBRV News NBRV Articles NBRV Message Board
Get NBRV Alerts

News, Short Squeeze, Breakout and More Instantly...